| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.2B | $4.1B | $3.7B | $3.3B | $2.8B | $2.3B | $2.5B | $2.3B |
| Cost of Revenue | $10.0B | $9.2B | $8.5B | $6.6B | $5.9B | $5.3B | $5.7B | $4.7B |
| Gross Profit | $1.6B | $1.6B | $1.6B | $1.5B | $1.2B | $0.9B | $1.0B | $1.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.7B | $1.6B | $1.5B | $1.4B | $1.2B | $1.0B | $1.1B | $1.0B |
| Operating Income | $1.1B | $1.1B | $1.1B | $1.0B | $0.7B | $0.5B | $0.6B | $0.6B |
| Net Income | $0.7B | $0.7B | $0.7B | $0.6B | $0.5B | $0.3B | $0.3B | $0.3B |
| EPS (Basic) | $10.30 | $10.50 | $10.04 | $9.20 | $6.65 | $4.11 | $4.51 | $3.84 |
| EPS (Diluted) | $10.27 | $10.47 | $10.01 | $9.15 | $6.61 | $4.09 | $4.49 | $3.80 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.9B | $28.2B | $25.6B | $24.2B | $20.3B | $17.9B | $19.0B | $18.1B |
| Current Assets | $3.6B | $3.2B | $2.9B | $2.7B | $2.2B | $2.0B | $1.8B | $1.8B |
| Cash & Equivalents | $0.5B | $0.5B | $0.4B | $0.1B | $0.1B | $0.2B | $0.1B | $0.0B |
| Total Liabilities | $20.9B | $19.5B | $17.5B | $17.1B | $14.3B | $13.3B | $15.1B | $14.7B |
| Current Liabilities | $3.8B | $3.3B | $3.6B | $2.4B | $2.6B | $1.9B | $2.2B | $2.1B |
| Stockholders' Equity | $9.0B | $8.6B | $8.1B | $7.1B | $6.0B | $4.5B | $3.8B | $3.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.2B | $4.5B | $4.7B | $4.4B | $3.7B | $2.7B | $3.0B | $2.9B |
| Investing Cash Flow | $-3.4B | $-4.1B | $-3.0B | $-5.0B | $-3.6B | $-0.2B | $-1.7B | $-4.6B |
| Capital Expenditures | — | — | — | — | — | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-1.8B | $-0.3B | $-1.5B | $0.6B | $-0.1B | $-2.3B | $-1.3B | $1.4B |